Molecular remission at T cell level in patients with rheumatoid arthritis

While numerous disease-modifying anti-rheumatic drugs (DMARDs) have brought about a dramatic paradigm shift in the management of rheumatoid arthritis (RA), unmet needs remain, such as the small proportion of patients who achieve drug-free status. The aim of this study was to explore key molecules fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Inamo, Jun, Suzuki, Katsuya, Takeshita, Masaru, Kondo, Yasushi, Okuzono, Yuumi, Koga, Keiko, Kassai, Yoshiaki, Takiguchi, Maiko, Kurisu, Rina, Yoshimura, Akihiko, Takeuchi, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371080/
https://www.ncbi.nlm.nih.gov/pubmed/34404865
http://dx.doi.org/10.1038/s41598-021-96300-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371080/
https://www.ncbi.nlm.nih.gov/pubmed/34404865
http://dx.doi.org/10.1038/s41598-021-96300-z

Ejemplares similares